Latest News

Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations  - stock.adobe.com.
Q1 2025: A recap of the top headlines and interviews

April 3rd 2025

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescentsLatest revision | Image Credit: © Stepan Popov - © Stepan Popov - stock.adobe.com.
Cingulate reports phase 3 safety data for CTx-1301 to treat ADHD in children, adolescents

March 4th 2025

ADHD with ASD and without it: Should they be treated differently? | Image credit: Contemporary Pediatrics
ADHD with ASD and without it: Should they be treated differently?

January 29th 2025

Background on digital therapeutics and what they can do for mental health | Image Credit: © Syda Productions - © Syda Productions - stock.adobe.com.
Digital therapeutics and what they can do for mental health

August 8th 2024

Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more

June 3rd 2024

More News

© 2025 MJH Life Sciences

All rights reserved.